Do not use GLP-1s if you: Have a personal or family history of certain types of thyroid cancer (e.g., medullary thyroid carcinoma) or multiple endocrine neoplasia type 2 Have had pancreatitis or gallbladder disease unless cleared by your doctor Are pregnant, planning to become pregnant, or breastfeeding Have severe gastrointestinal disease (consult your healthcare provider) Common side effects may include: Nausea, especially during the first few weeks Constipation or diarrhea Fatigue or low energy Mild stomach cramping Temporary decrease in appetite To reduce side effects, your provider will typically start with a low dose and increase gradually
Our team can help determine if its the right fit for you
No randomized trial has compared cagrilintide against tirzepatide directly
There are several reasons which make GLP-1 agonists an attractive option for Parkinsons disease
This is how the company landed on its unique, proprietary, patented resistant starch fibre blend (featuring green banana powder, beta-glucans from oats, soluble vegetable fibre from maize, and potato starch)
PMID: 35165272
